| Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19 C Cervia, J Nilsson, Y Zurbuchen, A Valaperti, J Schreiner, ... Journal of Allergy and Clinical Immunology 147 (2), 545-557. e9, 2021 | 448 | 2021 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 328 | 2020 |
| Persistent complement dysregulation with signs of thromboinflammation in active Long Covid C Cervia-Hasler, SC Brüningk, T Hoch, B Fan, G Muzio, RC Thompson, ... Science 383 (6680), eadg7942, 2024 | 183 | 2024 |
| LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies M Emmenegger, E De Cecco, M Hruska‐Plochan, T Eninger, ... EMBO molecular medicine 13 (9), e14745, 2021 | 69 | 2021 |
| Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region M Emmenegger, E De Cecco, D Lamparter, RPB Jacquat, J Riou, ... Iscience 26 (2), 2023 | 51* | 2023 |
| Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins M Emmenegger, SS Kumar, V Emmenegger, T Malinauskas, T Buettner, ... PloS Pathogens 17 (12), e1010118, 2021 | 37 | 2021 |
| Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma MM Schneider, M Emmenegger, CK Xu, IC Morales, G Meisl, P Turelli, ... Life science alliance 5 (2), 2022 | 34* | 2022 |
| Protective anti‐prion antibodies in human immunoglobulin repertoires A Senatore, K Frontzek, M Emmenegger, A Chincisan, M Losa, ... EMBO molecular medicine 12 (9), e12739, 2020 | 24 | 2020 |
| Lack of association between pandemic chilblains and SARS-CoV-2 infection JR Gehlhausen, AJ Little, CJ Ko, M Emmenegger, C Lucas, P Wong, ... Proceedings of the National Academy of Sciences 119 (9), e2122090119, 2022 | 23 | 2022 |
| Genome‐wide identification of microRNAs regulating the human prion protein D Pease, C Scheckel, E Schaper, V Eckhardt, M Emmenegger, I Xenarios, ... Brain Pathology 29 (2), 232-244, 2019 | 22 | 2019 |
| Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants M Emmenegger, S Fiedler, SD Brugger, SRA Devenish, AS Morgunov, ... Iscience 25 (8), 2022 | 15 | 2022 |
| High content genome-wide siRNA screen to investigate the coordination of cell size and RNA production M Müller, M Avar, D Heinzer, M Emmenegger, A Aguzzi, L Pelkmans, ... Scientific Data 8 (1), 162, 2021 | 10 | 2021 |
| An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein E Kara, A Crimi, A Wiedmer, M Emmenegger, C Manzoni, S Bandres-Ciga, ... Cell reports 35 (10), 2021 | 10 | 2021 |
| An arrayed genome‐wide perturbation screen identifies the ribonucleoprotein Hnrnpk as rate‐limiting for prion propagation M Avar, D Heinzer, AM Thackray, Y Liu, M Hruska‐Plochan, S Sellitto, ... The EMBO Journal 41 (23), e112338, 2022 | 9 | 2022 |
| Microfluidic antibody affinity profiling reveals the role of memory reactivation and cross-reactivity in the defense against SARS-CoV-2 V Denninger, CK Xu, G Meisl, AS Morgunov, S Fiedler, A Ilsley, ... ACS Infectious Diseases 8 (4), 790-799, 2022 | 8* | 2022 |
| Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration S Fiedler, SRA Devenish, AS Morgunov, A Ilsley, F Ricci, M Emmenegger, ... Scientific Reports 12 (1), 19791, 2022 | 6 | 2022 |
| Novel regulators of PrPC biosynthesis revealed by genome-wide RNA interference D Heinzer, M Avar, DP Pease, A Dhingra, JA Yin, E Schaper, B Doğançay, ... PLoS pathogens 17 (10), e1010013, 2021 | 6 | 2021 |
| The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis M Losa, M Emmenegger, P De Rossi, PM Schuerch, T Serdiuk, N Pengo, ... EMBO Molecular Medicine, 2024 | 4* | 2024 |
| Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk M Emmenegger, V Emmenegger, SM Shambat, TC Scheier, ... Clinical Immunology 257, 109845, 2023 | 4 | 2023 |
| Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling M Emmenegger, R Worth, S Fiedler, SRA Devenish, TPJ Knowles, ... STAR protocols 4 (1), 102095, 2023 | 4 | 2023 |